Has Herluf Lund received payments from drug or device companies?

Yes. Drug and device makers reported $7,387 in general payments to Herluf Lund across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Herluf Lund did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Herluf Lund come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Herluf Lund

Chesterfield, MONPI 1750318085

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,741 of the $7,387 with a category attached, or 64.2%. AbbVie accounts for 64.0% of it on its own, with 14 other manufacturers making up the rest.

$7,387in general payments, 2019–2025

Across 117 payments — averaging $63.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$5K
Davol Inc.$692
Mentor Worldwide LLC$318
Sientra, Inc.$317
Integra Lifesciences Corporation$293
Galderma Laboratories, L.p.$265
plus $777 from 9 others

$3,050in research payments, 2019–2025

Across 3 payments — averaging $1016.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$3K

What the payments were for

Consulting fees$1,29618%
Food & beverage$4,74164%
Gifts$1,35018%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	59	$4,726
Davol Inc.	6	$692
Mentor Worldwide LLC	4	$318
Sientra, Inc.	15	$317
Integra Lifesciences Corporation	2	$293
Galderma Laboratories, L.p.	15	$265
RTI Surgical, Inc	1	$154
Revance Therapeutics, Inc.	6	$136
Tepha Inc	2	$127
BD	1	$115
Axogen	1	$108
Motiva USA, LLC	1	$61
Merz North America, Inc.	2	$47
KCI USA, Inc.	1	$16
Cumberland Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NATRELLE SALINE-FILLED BREAST IMPLANTS$1,935
NATRELLE$1,577
REVOLVE$648
INTEGRA$462
Phasix Mesh$451
BOTOX$264
MENTOR MemoryGel Resterilizable Gel Sizer$209
ARTOURA Breast Tissue Expander$209
CORTIVA ALLOGRAFT DERMIS$154
INTEGRA DERMAL REGENERATION TEMPLATE$154
PRIMATRIX$154
Agento I.C. Silver-Coated Endotracheal Tube$146
BILAYER WOUND MATRIX (BWM)$139
INTEGRA WOUND MATRIX (IWM)$139
AMNIOEXCEL$139
IDRT$139
FLOWABLE$139
AxoGuard Nerve Protector$108
AxoGuard Nerve Connector$108

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CefuroximeCefuroxime Axetil	21	$265
Celecoxib	12	$116
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	11	$80

Paid to pharmacies, not to this prescriber.

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →